Clinical Professor of Medicine, UCSF
Endocrinology
David C. Klonoff works in the field of Endocrinology. He studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care He received 18 awards: "Fellow", "America's Top Doctors", "Fellow; Cited as one of the 1000 top bioengineers in the world, and as being one of the top 2% of the worlds bioengineers", "20th Annual Gold Medal Oration and Distinguished Scientist Award", "San Francisco Super Doctors (Endocrinology)", "Top Doctors in the US as being in the top 1% of endocrinologists nationally", "Director's Citation", "Special Citation Award for outstanding contributions to the Center for Devices and Radiological Health related to diabetes technology", "Physician of the Month", "Health Hero Award", "Cited in Outstanding Physician Specialists of the Bay Area and rated Best Endocrinologist in San Mateo County", "Distinguished Service Citation", "Dorothy Lang Frank Diabetes Fellowship", "Alpha Omega Alpha (junior year)", "Scholarship", "Citation", "Phi Beta Kappa (Junior Year)" and "Super Doctor". Doctor David C. Klonoff, MD is a published doctor. He published 102 publications, including: 'Noninvasive blood glucose monitoring.' He accepts Medicare.
Publications
- What Do Your Fingernails Say About You? Can They Indicate That You Have Diabetes?
- Development of the Diabetes Technology Society Blood Glucose Monitor System Surveillance Protocol.
- Afrezza Inhaled Insulin: The Fastest-Acting FDA-Approved Insulin on the Market Has Favorable Properties.
- Timely Hospital Glucose Measurement: Here Today, Gone Tomorrow?
- Hospital Diabetes meeting: arlington, virginia, may 13, 2014.
- Computing the surveillance error grid analysis: procedure and examples.
- The surveillance error grid.
- ADAG Study Group Data Links A1C Levels With Empirically Measured Blood Glucose Values - New Treatment Guidelines Will Now be Needed.
- Hypoglycemia Begets Hypoglycemia: The Order Effect in the ASPIRE In-Clinic Study.
- New Wearable Computers Move Ahead: Google Glass and Smart Wigs.
- Pathways to quality inpatient management of hyperglycemia and Diabetes: a call to action.
- Threshold-based insulin-pump interruption for reduction of hypoglycemia.
- SMBG Out of Control: The Need for Educating Patients About Control Solution.
- Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with Diabetes patients, caregivers, and healthcare professionals.
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP).
- Overview of fluorescence glucose sensing: a technology With a bright future.
- The current status of bolus calculator decision-support software.
- Improved outcomes from Diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support.
- Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline.
- A review of the security of insulin pump infusion systems.
- Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.
- Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 Diabetes.
- Innovations in technology for the treatment of Diabetes: clinical development of the artificial pancreas (an autonomous system).
- Smart sensors for maintaining physiologic homeostasis.
- The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia.
- Hospital Diabetes: why quality of care matters to both patients and hospitals.
- Improving the safety of blood glucose monitoring.
- Incretin therapy for type 2 Diabetes mellitus.
- Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose.
- Fibroblast growth factor: will this hormone be the hemoglobin A1c for managing phosphorus balance in chronic kidney disease?
- The food and drug administration is now preparing to establish tighter performance requirements for blood glucose monitors.
- Second insulin pump safety meeting: summary report.
- Regulatory controversies surround blood glucose monitoring devices.
- The need for a glycemia modeling comparison workshop to facilitate development of an artificial pancreas.
- The beneficial effects of a Paleolithic diet on type 2 Diabetes and other risk factors for cardiovascular disease.
- Progress in development of an artificial pancreas.
- The missing element of telemedicine for Diabetes: decision support software.
- The personalized medicine for Diabetes meeting summary report.
- Using telemedicine to improve outcomes in Diabetes--an emerging technology.
- A sweetened beverage tax is needed to combat the obesity epidemicas well as related absenteeism and presenteeism.
- Insulin pump safety meeting: summary report.
- Continuous glucose monitoring study does not demonstrate benefit in children and adolescents.
- Glutamic Acid decarboxylase therapy for recent-onset type 1 Diabetes: are we at the end or the beginning of finding a cure?
- The increasing incidence of Diabetes in the 21st century.
- United Kingdom prospective Diabetes study follow-up studies establish a legacy effect of therapy for hyperglycemia but not hypertension.
- Consensus report of the coalition for clinical research-self-monitoring of blood glucose.
- Drugs in the pipeline for the obesity market.
- Designing an artificial pancreas system to be compatible With other medical devices.
- Spending for Diabetes drugs is increasing in the United States.
- Personalized medicine for Diabetes.
- New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 Diabetes-when this practice is not applied properly.
- The "catalyst to better Diabetes care act of 2007".
- Summary of Seventh Annual Diabetes Technology Meeting October 25-27, 2007 San Francisco, California.
- Business and economics of Diabetes.
- The benefits of implanted glucose sensors.
- The new food and drug administration center for devices and radiological health engineering and physics laboratory and methods for testing software that controls infus...
- Bariatric surgery for obese adolescents.
- Replacements for trans fats-will there be an oil shortage?
- Subcutaneous continuous glucose monitoring in severe burn patients.
- Dirlotapide, a U.S. Food and Drug Administration-approved first-in-class obesity drug for dogs-will humans be next?
- Technology to treat hyperglycemia in trauma.
- Summary of Sixth Annual Diabetes Technology Meeting, November 2-4, 2006, Atlanta, Georgia.
- Metabolic effects of two years of exenatide treatment on Diabetes, obesity, and hepatic biomarkers in patients with type 2 Diabetes: an interim analysis of data from t...
- Benefits and limitations of self-monitoring of blood glucose.
- The need for performance standards for continuous glucose monitors.
- The artificial pancreas: how sweet engineering will solve bitter problems.
- A review of continuous glucose monitoring technology.
- Time synching or time sinking?
- Pyruvate therapy for severe hypoglycemia.
- Continuous glucose monitoring: roadmap for 21st century Diabetes therapy.
- An adaptive drug infusion system.
- The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges.
- Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical?
- The link between Diabetes, military metabolic monitoring, and NASA.
- A flaw in the use of sulfonylurea screening to diagnose sulfonylurea overdosages.
- Technology for portable measurement of blood lactate.
- Microdialysis of interstitial fluid for continuous glucose measurement.
- European trends in Diabetes technology--continuous glucose measurements and computerized information-processing tools.
- Current, emerging, and future trends in metabolic monitoring.
- The First Annual Diabetes Technology Meeting--a new forum for accelerating the development of technology to fight Diabetes.
- Twelve Modern Digital Technologies That Are Transforming Decision Making for Diabetes and All Areas of Health Care.
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile.
- Chronic fatigue syndrome.
- Insulinomas associated with multiple endocrine neoplasia Type I: the need for a different surgical approach.
- Acute water intoxication as a complication of urine drug testing in the workplace.
- Hyperprolactinemia in a patient With a pituitary and an ovarian dermoid tumor: case report.
- Stroke associated With cocaine use.
- Cryptosporidial and cytomegaloviral hepatitis and cholecystitis.
- Association of hyperinsulinemia With chlorpropamide toxicity.
- Macroamylasemia and other immunoglobulin-complexed enzyme Disorders.
- The Thyroid nodule.
- Hypoglycemia following inadvertent and factitious sulfonylurea overdosages.
- Inappropriate drug prescribing.
- Chronic fatigue syndrome and neurally mediated hypotension.
- ASPIRE In-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia.
- Noninvasive blood glucose monitoring.
- An economic analysis of interventions for Diabetes.
- Allen M. Spiegel, M.D., named Director of NIDDK.
- NIAID spearheads collaborative network for clinical research on immune tolerance.
- Clinical chemistry and clinical toxicology devices advisory panel recommendation on Glucowatch.
- Quality Control of Insulins and Biosimilar Insulins: What Do We Know?
Schools
University Of California San Francisco School Of Medicine
University Of California
Conditions Treated
- Diabetes Type 1
- Diabetes Type 2
- Diabetes With Renal Manifestations
- Goiter
- View All
Doctors Specialties
Accepted Insurances
Awards
- Fellow
- America's Top Doctors
- Fellow; Cited as one of the 1000 top bioengineers in the world, and as being one of the top 2% of the world’s bioengineers
- 20th Annual Gold Medal Oration and Distinguished Scientist Award
- San Francisco Super Doctors (Endocrinology)
- Top Doctors in the US as being in the top 1% of endocrinologists nationally
- Director's Citation
- Special Citation Award for outstanding contributions to the Center for Devices and Radiological Health related to diabetes technology
- Physician of the Month
- Health Hero Award
- Cited in “Outstanding Physician Specialists of the Bay Area†and rated Best Endocrinologist in San Mateo County
- Distinguished Service Citation
- Dorothy Lang Frank Diabetes Fellowship
- Alpha Omega Alpha (junior year)
- Scholarship
- Citation
- Phi Beta Kappa (Junior Year)
- Super Doctor
Education
-
UCSF
-
UCLA Medical Center
-
University of California San Francisco School of Medicine
Hospital
-
Mills-Peninsula Health Services
Drug Facts
| NPI NUMBER |
|
1306882949 |
| NPPES Provider LastName |
|
KLONOFF |
| NPPES Provider FirstName |
|
DAVID |
| NPPES Provider ZIPCode |
|
940103224 |
| NPPES Provider State |
|
CA |
| Specialty Description |
|
Internal Medicine |
| Total Claim Count |
|
391.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1306882949 |
| Last Name Of The Provider |
KLONOFF |
| First Name Of The Provider |
DAVID |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
